Robert Pickett, MD
Clinical Cardiac Electrophysiology · Nashville, TNNPI 1932128782
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (37.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 85.5% of it on its own, with 13 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 430 payments — averaging $221.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$82K
- Medtronic$12K
- Abbott$810
- Preventice Services, LLC$223
- Abiomed$130
- Irhythm Technologies, Inc.$88
- plus $156 from 8 others
Across 280 payments — averaging $3156.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$713K
- Janssen Research & Development, LLC$154K
- Medtronic$17K
What the payments were for
- Consulting fees$31,38833%
- Speaking & faculty fees$35,80038%
- Travel & lodging$12,80013%
- Food & beverage$15,31716%
- Education$980%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 264 | $81,597 |
| Medtronic(2 entities) | 136 | $12,398 |
| Abbott | 12 | $810 |
| Preventice Services, LLC | 2 | $223 |
| Abiomed | 1 | $130 |
| Irhythm Technologies, Inc. | 4 | $88 |
| Pfizer | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $15 |
| Cvrx, Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$18,689
- WATCHMAN Access System$14,153
- WATCHMAN FLX$8,612
- RHYTHMIA$6,671
- Farapulse$5,901
- Arctic Front$5,370
- Watchman$4,911
- GENERAL VASCULAR ACCESS$2,500
- Rhythmia Mapping System$2,000
- Micra$1,724
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$737
- GENERAL PAIN MANAGEMENT$421
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$398
- BG Mini Plus$187
- HeartMate 3 Left Ventricular Dev$173
- VersaCross Access Solution$166
- CardioMEMS HF System$144
- Impella$130
How this compares
$95,402 in reported general payments places this provider in the 90th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 719 | $725,776 |
| XareltoRivaroxaban | 310 | $315,320 |
| MultaqDronedarone Hcl | 34 | $52,111 |
| EntrestoSacubitril/Valsartan | 37 | $30,407 |
| Flecainide Acetate | 377 | $20,054 |
| Metoprolol Succinate | 652 | $13,033 |
| Dofetilide | 83 | $11,677 |
| Propafenone Hcl ErPropafenone Hcl | 25 | $8,738 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 73 | $4,953 |
| Amiodarone Hcl | 132 | $4,208 |
| SotalolSotalol Hcl | 202 | $4,149 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 11 | $2,276 |
| Bumetanide | 48 | $2,117 |
| Warfarin Sodium | 137 | $1,460 |
| Propafenone Hcl | 33 | $1,034 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $35 | $725,776719 claims |
| Johnson & JohnsonXarelto | $20 | $315,320310 claims |
| Sanofi-aventis U.S. LLCMultaq | $14 | $52,11134 claims |
| NovartisEntresto | $13 | $30,40737 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Nashville
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- William StevensonNashville$172K
- Sandeep DuggalNashville$151K
- Sean WhalenNashville$149K
- Harikrishna TandriNashville$97K
- Robert JonesNashville$57K
- Giovanni Davogustto CataldoNashville$42K
- Jonathan GandhiNashville$36K
- Ricardo LugoNashville$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.